Connor, Clark & Lunn Investment Management (CC&L)
BHC icon

Connor, Clark & Lunn Investment Management (CC&L)’s Bausch Health BHC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70,900
Closed -$593K – 1115
2022
Q2 		$593K Buy
+70,900
New +$991K ﹤0.01% 739
2021
Q2 		– Sell
-201,900
Closed -$6.41M – 977
2021
Q1 		$6.41M Sell
201,900
-2,056,592
-91% -$60.3M 0.04% 308
2020
Q4 		$46.9M Sell
2,258,492
-1,372,602
-38% -$25.6M 0.28% 78
2020
Q3 		$56.4M Sell
3,631,094
-1,762,793
-33% -$30.4M 0.38% 59
2020
Q2 		$98.7M Buy
5,393,887
+828,450
+18% +$14.6M 0.7% 30
2020
Q1 		$70.8M Sell
4,565,437
-77,334
-2% -$1.86M 0.63% 36
2019
Q4 		$139M Sell
4,642,771
-1,248,539
-21% -$32.5M 0.96% 24
2019
Q3 		$129M Sell
5,891,310
-409,895
-7% -$9.38M 0.88% 27
2019
Q2 		$159M Sell
6,301,205
-908,013
-13% -$21.6M 1.02% 22
2019
Q1 		$178M Sell
7,209,218
-1,243,446
-15% -$29.7M 1.17% 17
2018
Q4 		$156M Buy
8,452,664
+75,175
+0.9% +$1.79M 1.06% 22
2018
Q3 		$215M Buy
8,377,489
+474,597
+6% +$10.9M 1.22% 16
2018
Q2 		$184M Sell
7,902,892
-1,005,185
-11% -$20.8M 1.03% 22
2018
Q1 		$142M Buy
8,908,077
+3,273,855
+58% +$60.9M 0.86% 26
2017
Q4 		$118M Sell
5,634,222
-1,317,500
-19% -$20.9M 0.69% 31
2017
Q3 		$99.4M Buy
6,951,722
+2,070,109
+42% +$31.3M 0.6% 37
2017
Q2 		$84.7M Buy
4,881,613
+3,406,617
+231% +$40.8M 0.56% 37
2017
Q1 		$16.2M Buy
1,474,996
+1,142,570
+344% +$15.7M 0.11% 133
2016
Q4 		$4.83M Sell
332,426
-1,878,630
-85% -$34.5M 0.03% 257
2016
Q3 		$54.2M Buy
2,211,056
+324,740
+17% +$8.4M 0.38% 46
2016
Q2 		$37.8M Buy
1,886,316
+313,805
+20% +$8.89M 0.28% 66
2016
Q1 		$41.4M Sell
1,572,511
-1,203,441
-43% -$89M 0.32% 49
2015
Q4 		$281M Sell
2,775,952
-720,225
-21% -$80.9M 2.35% 9
2015
Q3 		$621M Buy
3,496,177
+279,710
+9% +$65.2M 5.04% 3
2015
Q2 		$714M Sell
3,216,467
-156,506
-5% -$34.7M 6.49% 2
2015
Q1 		$666M Buy
3,372,973
+730,914
+28% +$130M 5.61% 3
2014
Q4 		$379M Sell
2,642,059
-209,782
-7% -$28.2M 3.07% 9
2014
Q3 		$374M Sell
2,851,841
-628,586
-18% -$74.9M 3.03% 10
2014
Q2 		$470M Sell
3,480,427
-367,175
-10% -$46.8M 3.32% 7
2014
Q1 		$560M Sell
3,847,602
-403,576
-9% -$55.2M 4.09% 5
2013
Q4 		$530M Buy
4,251,178
+449,390
+12% +$49.2M 4.13% 5
2013
Q3 		$408M Buy
3,801,788
+50,175
+1% +$4.89M 3.66% 6
2013
Q2 		$340M Buy
+3,751,613
New +$296M 3.27% 7

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BHC Position: Q3 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 70,900 shares — an estimated $593K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BHC in Q2 2013 and held it in 33 quarters. The position peaked at $714M in Q2 2015. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 70,900 Bausch Health shares in Q3 2022, an estimated $593K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Bausch Health in Q2 2013 and held it in 33 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Bausch Health position peaked at $714M in Q2 2015.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.